Aurum Biosciences Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$13.4M
- Investors
-
6
Aurum Biosciences General Information
Description
Developer of novel pharmaceuticals designed for patients with acute ischaemic stroke. The company's pharmaceuticals carry and deliver oxygen independent of hemoglobin and have the potential to be used in multiple indications where oxygen is required, enabling physicians to provide safe therapy that can be given irrespective of the time window.
Contact Information
Website
www.aurumbiosciences.comCorporate Office
- Imaging Centre of Excellence
- Queen Elizabeth University Hospital Campus, Langlands Road
- Glasgow G51 4LB
- Scotland, United Kingdom
Corporate Office
- Imaging Centre of Excellence
- Queen Elizabeth University Hospital Campus, Langlands Road
- Glasgow G51 4LB
- Scotland, United Kingdom
Aurum Biosciences Timeline
Aurum Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | $13.4M | In Progress | Generating Revenue | |||
| 6. Later Stage VC | 30-Aug-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 18-Jan-2024 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 25-Sep-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | 01-Sep-2015 | Completed | Startup | |||
| 2. Angel (individual) | Completed | Startup | ||||
| 1. University Spin-Out | 01-Nov-2010 | Completed | Startup |
Aurum Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 790,307 | $0.000134 | $1.15 | $1.15 | 1x | $1.15 | 25.34% | |
| Ordinary | 1,007,000 | $0.000134 | $1.34 | $1.34 | 1x | $1.34 | 32.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aurum Biosciences Comparisons
Industry
Financing
Details
Aurum Biosciences Competitors (55)
One of Aurum Biosciences’s 55 competitors is GentiBio, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GentiBio | Venture Capital-Backed | Cambridge, MA | ||||
| Endeavor BioMedicines | Venture Capital-Backed | San Diego, CA | ||||
| American Gene Technologies | Venture Capital-Backed | Rockville, MD | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Apeptico | Formerly VC-backed | Vienna, Austria |
Aurum Biosciences Patents
Aurum Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2925223-A1 | Improved methods of assessing metabolic function | Active | 27-Nov-2012 | ||
| EP-2925223-B1 | Improved methods of assessing metabolic function | Active | 27-Nov-2012 | ||
| US-20150313540-A1 | Improved methods of assessing metabolic function | Active | 27-Nov-2012 | ||
| ES-2933929-T3 | Improved methods to assess metabolic function | Active | 27-Nov-2012 | ||
| US-10278642-B2 | Methods of assessing metabolic function | Active | 27-Nov-2012 | A61B5/4866 |
Aurum Biosciences Signals
Aurum Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Infinion Biopharma | Investment Bank | Minority | ||
| InnoScot Health | Corporation | Minority | ||
| Scottish Enterprise | Growth/Expansion | Minority | ||
| TRICAPITAL Angel Investors | Angel Group | Minority | ||
| Wellcome Trust | Limited Partner | Minority |
Aurum Biosciences FAQs
-
When was Aurum Biosciences founded?
Aurum Biosciences was founded in 2010.
-
Where is Aurum Biosciences headquartered?
Aurum Biosciences is headquartered in Glasgow, United Kingdom.
-
What is the size of Aurum Biosciences?
Aurum Biosciences has 5 total employees.
-
What industry is Aurum Biosciences in?
Aurum Biosciences’s primary industry is Drug Discovery.
-
Is Aurum Biosciences a private or public company?
Aurum Biosciences is a Private company.
-
What is Aurum Biosciences’s current revenue?
The current revenue for Aurum Biosciences is .
-
How much funding has Aurum Biosciences raised over time?
Aurum Biosciences has raised $3.75M.
-
Who are Aurum Biosciences’s investors?
Infinion Biopharma, InnoScot Health, Scottish Enterprise, TRICAPITAL Angel Investors, and Wellcome Trust are 5 of 6 investors who have invested in Aurum Biosciences.
-
Who are Aurum Biosciences’s competitors?
GentiBio, Endeavor BioMedicines, American Gene Technologies, Inovio Pharmaceuticals, and Apeptico are some of the 55 competitors of Aurum Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process